Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
---|
03/28/1995 | US5401750 Derivatives of substituted imidazol-2-one and process for their preparation |
03/28/1995 | US5401721 Antiulcer agents and antisecretory agents |
03/28/1995 | CA2029046C Sustained release compositions for treating periodontal disease |
03/23/1995 | WO1995007934A2 Il8 inhibitors |
03/23/1995 | WO1995007886A1 3-amino-5-carboxy-substituted piperidines and 3-amino-4-carboxy-substituted pyrrolidines as tachykinin antagonists |
03/23/1995 | WO1995007710A1 Remedy for wound |
03/23/1995 | WO1995003333A3 Tryptase inhibitor |
03/23/1995 | CA2149323A1 Therapeutic agent for treating wounds |
03/22/1995 | EP0643770A1 Helicobacter pylori proteins useful for vaccines and diagnostics |
03/22/1995 | EP0643712A1 Spiro-oxetanes, process for preparing the same and medicaments |
03/22/1995 | EP0643579A1 Triazole substituted quinoline derivatives |
03/22/1995 | EP0301087B1 Peptide |
03/22/1995 | CN1100414A Preparation of pharmaceutical compound containing novel derivative of leukol |
03/22/1995 | CN1100303A L-2',3'-dideoxy nucleoside analogs as anti-hepatitis B (HBV) and anti-HIV agents |
03/21/1995 | US5399748 Derivatives of aspartic acid and glutamic acid having anticholecystokinin activity |
03/21/1995 | US5399696 Excitatory amino acid receptor antagonists; nervous system disorders |
03/21/1995 | US5399587 Biologically active compounds |
03/21/1995 | US5399556 Complex of ranitidine and a zinc citrate; gastrointestinal disorders, peptic ulcers |
03/16/1995 | WO1995007274A1 Bicyclic aromatic compounds as therapeutic agents |
03/16/1995 | WO1995007261A1 Polyamidic acid derivatives with antigastrin activity, a method for their preparation, and their pharmaceutical use |
03/16/1995 | WO1995007098A1 Methods for regulating gastrointestinal motility |
03/16/1995 | WO1995007097A1 Inhibition of heparin-binding |
03/16/1995 | WO1995007080A1 A method of treating liver disease and like indications with vasodilating agents |
03/16/1995 | WO1995007078A1 Epibatidine and derivatives thereof as cholinergic receptor agonists and antagonists |
03/16/1995 | CA2171440A1 Epibatidine and derivatives thereof as cholinergic receptor agonists and antagonists |
03/16/1995 | CA2170648A1 Polyamidic acid derivatives with antigastrin activity, a method for their preparation, and their pharmaceutical use |
03/16/1995 | CA2170056A1 1,4-benzodioxane derivatives for treating cns disorders |
03/16/1995 | CA2169633A1 Inhibition of heparin-binding |
03/15/1995 | EP0643068A1 Erythromycin derivative |
03/15/1995 | EP0642589A1 Method and reagent for inhibiting viral replication |
03/15/1995 | EP0642516A1 Macrocyclic immunomodulators |
03/15/1995 | EP0642504A1 (3s,4s)-delta-6-tetrahydrocannabinol-7-oic acids and derivatives thereof, processes for their preparation and pharmaceutical compositions containing them |
03/15/1995 | EP0642500A1 4-amino-3-acyl quinoline derivatives and their use as inhibitors of gastric acid secretion |
03/15/1995 | EP0642351A1 New pharmaceutical uses of krill enzymes |
03/15/1995 | EP0642348A1 Antibiotic cryptdin peptides and methods of their use |
03/15/1995 | EP0642340A1 Compositions based on histamine h 2?-receptor antagonists and cationic exchangers complexes |
03/15/1995 | EP0510028B1 Thioformamide derivatives |
03/15/1995 | CN1027893C Pharmaceutical composition containing 1,2-dithioheterocyclicpentene-3-trione-5-oxide |
03/14/1995 | US5397800 Gastrointestinal disorders |
03/14/1995 | US5397788 Antitumor agents, antiulcer agents, antipsychotics or anxiety |
03/14/1995 | US5397703 Method for generation of antibodies to cell surface molecules |
03/14/1995 | US5397694 For treatment of periodontal disease |
03/14/1995 | CA2029047C Sustained release compositions for treating periodontal disease |
03/09/1995 | WO1995006645A1 Benzofuran derivatives as tachykinin antagonists |
03/09/1995 | WO1995006637A1 Indole and indoline derivatives as 5ht1d receptor antagonists |
03/09/1995 | WO1995006464A1 Pharmaceutical preparations for the targeted treatment of morbus crohn and colitis ulcerosa |
03/09/1995 | WO1995001782A3 Method for making freeze dried drug dosage forms |
03/08/1995 | EP0641340A1 NEW 3-(SUBSTITUTED TETRAZOLYL)-4-OXO-4H-PYRIDO- 1,2-a]PYRIMIDINES, SALTS THEREOF, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESS FOR PREPARING SAME |
03/08/1995 | EP0641217A1 Amylase-electrolyte oral rehydration method and apparatus |
03/02/1995 | WO1995006044A1 Amide and urea derivatives as 5ht1d receptor antagonists |
03/02/1995 | WO1995006040A1 Benzodiazepine compounds useful as antagonists of cck or of gastrine |
03/02/1995 | WO1995005849A1 Inducing antibody response against self-proteins with the aid of foreign t-cell epitopes |
03/02/1995 | WO1995005814A1 Pharmaceutical compositions comprising metal complexes |
03/02/1995 | WO1994025601A3 New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents |
03/02/1995 | DE4407859C1 Vector for liver-specific gene therapy |
03/02/1995 | CA2170253A1 Pharmaceutical compositions comprising metal complexes |
03/02/1995 | CA2169089A1 Benzodiazepine derivatives |
03/01/1995 | EP0640602A1 Benzo[b]furancarboxamide derivatives, process for their preparation and their use as gastrointestinal mobility-enhancing agents |
03/01/1995 | EP0640593A1 Substituted benzoylguanidines, process for their preparation, their use as medicine or in diagnostic and medicines containing them |
03/01/1995 | EP0640592A1 N-acylated tricyclic azaheterorings useful as vasopressin antagonists |
03/01/1995 | EP0640345A2 Composition for inhibiting transmission of AIDS, containing silver salts with a detergent |
03/01/1995 | EP0640344A1 Pharmaceutical composition in liquid dosage form containing ursodeoxycholic acid |
03/01/1995 | EP0640339A1 Methods for inhibiting bone loss and cartilage degradation using wortmannin and its analogs |
03/01/1995 | EP0640082A1 Heteroaromatic quinuclidinenes, their use and preparation |
03/01/1995 | EP0640081A1 Substituted phenylcarbamates and phenylureas, their preparation and their use as 5-ht antagonists |
03/01/1995 | EP0518908B1 Method for polymerization of epoxide compounds |
03/01/1995 | CN1099291A Oral pill for treatment of hepatic disease |
03/01/1995 | CA2131116A1 Composition for rectal administration |
02/28/1995 | US5393762 Pharmaceutical agents for treatment of emesis |
02/28/1995 | US5393745 Method for treating aphthae using dimethylpolysiloxane |
02/28/1995 | US5392725 Sewing machine needle and method for manufacturing same |
02/28/1995 | CA1334589C Benzodiazepine derivatives |
02/26/1995 | CA2130617A1 Methods for inhibiting bone loss and cartilage degradation using wortmannin and its analogs |
02/23/1995 | WO1995005363A1 Amidine derivatives with nitric oxide synthetase activities |
02/23/1995 | WO1995005359A1 Bicyclo (2.2.2) octane derivatives cholecystokinin and/or gastrin antagonists |
02/23/1995 | WO1995005180A1 Methods and compositions for inhibiting uridine secretion |
02/23/1995 | CA2169280A1 Amidine derivatives with nitric oxide synthetase activities |
02/23/1995 | CA2167156A1 Bicyclo(2.2.2) octane derivatives cholecystokinin and/or gastin antagonists |
02/22/1995 | EP0639079A1 Methods for treating interleukin-1 and tumor necrosis factor mediated diseases |
02/22/1995 | EP0609394A4 Anti-explosion pads and their method of use. |
02/22/1995 | CN1098924A "Baiyunxiandan" Chinese medicinal capsule |
02/22/1995 | CN1098907A Dry mix formulation for bisphosphonic acids |
02/21/1995 | US5391752 Oxidizing a cooled mixture of pyrmetazole and solvent to obtain omeprazole |
02/21/1995 | US5391574 Antispasmodic agents |
02/21/1995 | US5391555 Administering 2-(4(2-quinolinyl-methoxy)-phenyl)-acetic acid derivatives; Crohn's disease |
02/21/1995 | US5391549 Cinnoline-3-carboxylic acid derivatives |
02/16/1995 | WO1995004819A1 NEW GROWTH/DIFFERENTIATION FACTOR OF THE TGF-β FAMILY |
02/16/1995 | WO1995004752A1 Therapeutic peptide derivatives |
02/16/1995 | WO1995004735A1 Matrix metalloprotease inhibitors |
02/16/1995 | WO1995004730A1 Benzopyrans and pharmaceutical compositions containing them |
02/16/1995 | WO1995004720A2 Gastrin and cck receptor ligands |
02/16/1995 | WO1995004520A1 Method and composition for treating muco-epidermal and epidermal pain, inflammation and infection |
02/16/1995 | CA2168791A1 Matrix metalloprotease inhibitors |
02/16/1995 | CA2167154A1 Gastrin and cck receptor ligands |
02/16/1995 | CA2146547A1 Method and composition for treating muco-epidermal and epidermal pain, inflammation and infection |
02/15/1995 | EP0638572A1 Bicyclic derivatives of imidazole, process for their preparation, intermediates; their application as medicaments and pharmaceutical compostions containing them |
02/15/1995 | EP0638553A1 Carboxylic acid amides having a terminal carboxylic acid group as aggregation inhibiting drugs |
02/15/1995 | EP0638548A1 Urea-subsituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic agent and a medicament containing them |
02/15/1995 | EP0638321A1 Ipriflavone and pharmaceutical compositions and their use for bone defect substitution |
02/15/1995 | EP0638082A1 Macrocyclic immunomodulators |